FDA guidance
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
FDA guidance · Final · issued Mar 8, 2010
Key facts
| Title | S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers |
|---|---|
| Status | Final |
| Issue date | Mar 8, 2010 |
| Center | Center for Drug Evaluation and Research |
| Issuing office | Center for Biologics Evaluation and Research, Center for Drug Evaluation and Research |
| Communication type | Guidance Document |
| Regulated product | Drugs |
| Docket number | FDA-2009-D-0006 |
| Comments close | Nov 16, 2016 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents